SCHEMBL6203723

SCHEMBL6203723

O=[C]C(C=O)N1CCCC1

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
FDPS P14324 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2482738 0.78
SCHEMBL3667855 0.78
SCHEMBL2483103 0.76 LMNA (0.32) LMNAMAPTHTTFDPS
SCHEMBL2484172 0.75
SCHEMBL18343465 0.73
SCHEMBL2481228 0.73 LMNA (0.31) LMNAMAPTHTTFDPS
SCHEMBL2483432 0.70
SCHEMBL2021999 0.69
SCHEMBL26091887 0.67 FDPS (0.35) LMNAMAPTHTTFDPS
SCHEMBL2484029 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP claimed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO claimed